Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02001558 · ClinicalTrials.gov registry record · Phase 4
Pressure Ulcer Healing With Microcyn
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 65
- Enrollment target
NCT02001558 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 65 participants.
The verdict
NCT02001558, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to test how well Microcyn™ works on Stage 3 and Stage 4 pressure ulcers compared to sterile saline among persons with spinal cord injury.
Interventions
- OTHER Sterile saline
- DRUG Microcyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2013-03 |
| Est. Completion | 2017-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02001558
The ClinicalTrials.gov registry entry for NCT02001558 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sterile saline is the first listed.
NCT02001558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02001558 about?
NCT02001558 is a clinical study titled "Pressure Ulcer Healing With Microcyn". The purpose of this study is to test how well Microcyn™ works on Stage 3 and Stage 4 pressure ulcers compared to sterile saline among persons with spinal cord injury.
What is the current status of trial NCT02001558?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 65 participants. The study started on 2013-03. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02001558?
The interventions under investigation include: Sterile saline (OTHER), Microcyn (DRUG).
Who is sponsoring clinical trial NCT02001558?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.